OncoCyte Corporation (OCX)
NASDAQ: OCX · Real-Time Price · USD
2.770
-0.040 (-1.42%)
At close: May 13, 2025, 4:00 PM
2.770
0.00 (0.00%)
After-hours: May 13, 2025, 4:05 PM EDT

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20
Diagnostic Tests
1.50M
Log In
Log In
Log In
Diagnostic Tests Growth
56.89%
Log In
Log In
Log In

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20
United States
916.83K
Log In
Log In
Log In
United States Growth
25.24%
Log In
Log In
Log In
Non-United States
586.17K
Log In
Log In
Log In
Non-United States Growth
160.24%
Log In
Log In
Log In